While no medication is entirely without risk, a significant body of research has identified a class of drugs called anticholinergics as being linked to an increased risk of dementia, especially with long-term use in older adults .
🧠 The Link Between Anticholinergics and Dementia
Anticholinergic medications work by blocking a key chemical messenger in the brain and body called acetylcholine, which plays a vital role in learning, memory, and attention . This mechanism, while effective for treating certain conditions, can interfere with cognitive function and has been associated with an increased risk of dementia .
💊 Specific Drugs Under Scrutiny
Based on recent studies, researchers have identified several anticholinergic drugs that show a particularly strong association with dementia risk:
| Drug Name | Primary Use | Key Finding on Dementia Risk |
|---|---|---|
| Oxybutynin | Overactive bladder | Consistently linked with substantially increased risk in multiple studies . |
| Tolterodine | Overactive bladder | Strongly associated with increased risk . |
| Solifenacin | Overactive bladder | Associated with an increased risk . |
| Antipsychotics (e.g., quetiapine, clozapine) | Various psychiatric conditions | Have been linked to a higher incidence of dementia in pharmacovigilance studies . |
| Valproate | Seizures, mood disorders | Included in a list of drugs with a high risk signal for dementia in a 2025 study . |
| Tramadol | Pain management | Identified as having a high risk signal for dementia . |
A Note on Risk: The risk appears to vary by drug. For example, while oxybutynin and tolterodine are consistently associated with higher risk, other anticholinergic bladder medications like trospium chloride and fesoterodine have not shown the same level of concern in some studies . It’s also important to note that not all studies agree, and the overall risk increase for some drugs is small .
